Sarepta Therapeutics
SRPT
#1355
Rank
$10.05 B
Marketcap
$114.82
Share price
3.80%
Change (1 day)
18.03%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2022 (TTM): -$0.51 B

According to Sarepta Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.51 B. In 2021 the company made an earning of -$0.42 B an increase over its 2020 earnings that were of -$0.56 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)-$0.51 B19.83%
2021-$0.42 B-24.25%
2020-$0.56 B-22.53%
2019-$0.72 B96.87%
2018-$0.37 B645.68%
2017-$48.63 M-81.81%
2016-$0.27 B21.47%
2015-$0.23 B62.04%
2014-$0.14 B21.26%
2013-$0.12 B277.02%
2012-$29.71 M-17.32%
2011-$35.93 M71.58%
2010-$20.94 M35.02%
2009-$15.51 M-11.59%
2008-$17.55 M-47.02%
2007-$33.11 M0.38%
2006-$32.99 M88.3%
2005-$17.52 M-30.06%
2004-$25.05 M32.69%
2003-$18.88 M-25.52%
2002-$25.35 M64.52%
2001-$15.41 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$5.54 B-1,205.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.55 B 8.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.43 B 184.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.82 B 62.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.4 B-22.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.21 B-58.92%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.15 B-70.57%๐Ÿ‡บ๐Ÿ‡ธ USA